Добірка наукової літератури з теми "Mortalité à long terme"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Mortalité à long terme".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Mortalité à long terme"
Adams, T. D., R. E. Gress, S. C. Smith, R. C. Halverson, S. C. Simper, W. D. Rosamond, M. J. Lamonte, A. M. Stroup, and S. C. Hunt. "Mortalité à long-terme après bypass gastrique pour obésité." Journal de Chirurgie 145, no. 1 (February 2008): 77–78. http://dx.doi.org/10.1016/s0021-7697(08)70287-4.
Повний текст джерелаDiab, D., F. Haziza, S. Russel, P. de Lentdecker, E. Lanzac, M. Debauchez, and H. Benamer. "Endocardites infectieuses opérées : indications chirurgicales, complications, mortalité intrahospitalière et à long terme." Annales de Cardiologie et d'Angéiologie 69, no. 6 (December 2020): 385–91. http://dx.doi.org/10.1016/j.ancard.2020.09.037.
Повний текст джерелаWoods, Robert, and Naomi Williams. "Must the gap widen before it can be narrowed? Long-term trends in social class mortality differentials." Continuity and Change 10, no. 1 (May 1995): 105–37. http://dx.doi.org/10.1017/s0268416000002514.
Повний текст джерелаBosson, Jean-Luc, Céline Vermorel, Carole Rolland, Gudrun Böge, Marie-Antoinette Sevestre, Gilles Pernod, and Jean-Philippe Galanaud. "Devenir à très long terme des patients inclus dans OPTIMEV (étude SPOT) : Volet 1 la mortalité." JMV-Journal de Médecine Vasculaire 47 (March 2022): S3—S4. http://dx.doi.org/10.1016/j.jdmv.2022.01.080.
Повний текст джерелаPhilip-Joet, F. "Chez l’insuffisant cardiaque, l’existence d’apnées du sommeil ne semble pas modifier la mortalité à long terme." Revue des Maladies Respiratoires 22 (June 2005): 158–59. http://dx.doi.org/10.1016/s0761-8425(05)73040-0.
Повний текст джерелаNesseler, Nicolas, Yoann Launey, Caroline Aninat, Jennifer White, Anne Corlu, Yannick Mallédant, and Philippe Seguin. "La dysfonction hépatique au cours du choc septique est associée à la mortalité a long terme." Anesthésie & Réanimation 1 (September 2015): A218. http://dx.doi.org/10.1016/j.anrea.2015.07.333.
Повний текст джерелаDramé, M., M. Kack, A. Debart, B. Courtaigne, I. Lanièce, B. de Wazières, C. Jeandel, F. Blanchard, D. Jolly, and J. L. Novella. "Facteurs prédictifs de mortalité à long terme chez des patients âgés hospitalisés en urgence : la cohorte Safes." Revue d'Épidémiologie et de Santé Publique 57 (May 2009): S22. http://dx.doi.org/10.1016/j.respe.2009.02.075.
Повний текст джерелаTukenova, M., C. Guibout, O. Oberlin, F. Doyon, A. Moussannif, N. Haddy, S. Guérin, et al. "Mortalité globale et par maladies cardiovasculaires à long terme après traitement d’un cancer de l’enfant : rôle du traitement." Revue d'Épidémiologie et de Santé Publique 56, no. 5 (September 2008): 298. http://dx.doi.org/10.1016/j.respe.2008.06.143.
Повний текст джерелаDel Panta, Lorenzo. "Mortalité infantile et post-infantile en Italie du XVIIIe au XXe siècle : tendances à long terme et différences régionales." Annales de démographie historique 1994, no. 1 (1994): 45–60. http://dx.doi.org/10.3406/adh.1994.1858.
Повний текст джерелаPilon-Marien, Laurence, Alain Gagnon, Bertrand Desjardins, and Robert Bourbeau. "Conditions de vie durant l’enfance et longévité : évaluation d’une base de données créée à partir du recensement canadien de 1901 et de l’état civil québécois1." Cahiers québécois de démographie 38, no. 1 (June 16, 2010): 171–91. http://dx.doi.org/10.7202/039992ar.
Повний текст джерелаДисертації з теми "Mortalité à long terme"
Nesseler, Nicolas. "Choc septique et devenir à long terme : impact de la dysfonction hépatique." Thesis, Rennes 1, 2015. http://www.theses.fr/2015REN1B029.
Повний текст джерелаKnowledge regarding long-term outcome after septic shock is limited. Additionally, the liver, which plays a key role during the septic illness, could significantly impact the long term outcome. First, in a surgical cohort of septic shock patients, we found that the 6-month mortality rate remained high. Baseline health-related quality of life (HRQOL) was found to be lower than in the general population and although HRQOL improved 6 months after the onset of septic shock, HRQOL remained lower than in the general population. In a second work including a large multicenter cohort of septic patients, we found a significant relationship between the occurrence or the worsening of liver dysfunction during the course of septic shock and mortality at 6 months; however, this relationship was not found in the patients with baseline liver dysfunction. At last, experimentally, we established a hepatocyte-macrophage co-culture model and septic shock was mimicked by lipopolysaccharide (LPS) treatment. We found that a catecholamine frequently used in septic shock such as epinephrine was able to shift the innate immune response toward a pro-inflammatory environment even when a low anti-inflammatory response was observed in macrophages and these effects were cAMP dependent but PKA/epac independent
Tukenova, Markhaba. "Mortalité spécifique et évènements iatrogènes peu étudiés survenant à très long terme après traitement d'un cancer de l'enfant." Paris 11, 2010. http://www.theses.fr/2010PA11T063.
Повний текст джерелаEspagnacq, Maude. "Mortalité à long terme et devenir social des blessés médullaires tétraplégiques. Etudes à partir des enquêtes Tétrafigap 1995 et 2006." Phd thesis, Université Panthéon-Sorbonne - Paris I, 2008. http://tel.archives-ouvertes.fr/tel-00360948.
Повний текст джерелаDans une première partie, les concepts sur le handicap, les spécificités de la blessure sont définis. La création du second questionnaire et les modalités de mise en place de l'enquête sont présentées. Puis on s'intéresse à la surmortalité, aux facteurs pronostiques et aux causes de décès. Enfin, on détermine les facilitateurs et les obstacles de la participation sociale au travers de deux exemples, la conjugalité et l'emploi.
Espagnacq, Maude. "Mortalité à long terme et devenir social des blessées medullaires tétraplégiques : études à partir des enquêtes Tétrafigap 1995 et 2006." Paris 1, 2008. https://tel.archives-ouvertes.fr/tel-00360948.
Повний текст джерелаPerron, Jean-Marie. "Les abcès endocardiques de l'anneau aortique dans l'endocardite infectieuse : étude monocentrique de 60 cas, prise en charge thérapeutique et mortalité à long terme." Bordeaux 2, 2000. http://www.theses.fr/2000BOR23089.
Повний текст джерелаJacquin, Laurent. "Déséquilibre d’oxygénation et lésions myocardiques aiguës : approche clinique en service d’accueil des urgences." Thesis, Lyon, 2021. https://n2t.net/ark:/47881/m6736qrr.
Повний текст джерелаIn the first part, we were interested in the criteria of oxygen supply/demand imbalance involved in the occurrence of a type 2 infarction. We explored in 610 patients the association between the parameters of these criteria and the occurrence of acute myocardial injury and type 2 infarction, as well as the correlation between these parameters and the extent of myocardial injury. Our results did not show any association between the importance of oxygen mismatch and the occurrence of acute myocardial injury. There was also no correlation with the magnitude of such injury. Therefore, we could not define strict restrictive thresholds that could be considered a significant myocardial stressor. In the second part, we compared the short-term and the long-term outcomes of patients admitted with an oxygen supply/demand imbalance condition according to the presence of myocardial injury or type 2 infarction and assessed the association of these pathological entities with mortality and major cardiovascular events. In this population of 824 patients, the occurrence of myocardial injury or type 2 infarction led to high in-hospital mortality of more than 20% and was significantly associated with it after adjustment for patient characteristics. In the follow-up of survivors, the outcome was dependent on comorbidities without the involvement of the occurrence of these initial myocardial injuries, with mortality rates of 27 to 35% and major cardiovascular events of 23 to 40%. We proposed to compare these results in another study, conducted prospectively, with a standardized 6-month follow-up of patients admitted for oxygenation failure, the methods of which are detailed here. This cohort consists of 670 patients whose data are currently being analyzed. Finally, in the third part, we focused on the 675 elderly patients, who represent more than 80% of our cohort, to determine the factors associated with the occurrence of these myocardial injuries and type 2 infarction according to age classes. We found very dependent patient profiles in these classes, linked to the epidemiological changes of aging. However, the individualization of type 2 myocardial infarction within acute myocardial lesions was not obvious, nor was the impact on mortality, which was essentially based on the burden of comorbidities
Munteanu, Mona. "Performances pronostiques du FibroTest chez les sujets avec maladie métabolique du foie Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference." Thesis, Sorbonne université, 2018. http://www.theses.fr/2018SORUS591.
Повний текст джерелаThe FibroTest (Patent APHP-Sorbonne University) has been validated as a biomarker for the diagnosis of the stages of fibrosis in non-alcoholic-fatty liver disease (NAFLD) with results similar to those in chronic hepatitis C, B and alcoholic liver disease (ALD), but it has not yet been confirmed for the prediction of liver-related death. This was mainly due to the lower incidence of liver related deaths, and the higher incidence of non-liver related deaths, as well as the slower progression of fibrosis to cirrhosis, in NAFLD in comparison with other liver diseases. The primary aim was to assess the long-term (10-year) prognostic value of FibroTest in NAFLD and in comparison with that observed in CHC, the most validated population. Due to the very early start of the FibroFrance project in 1997, FibroTest was prospectively assessed in the Pitié-Salpêtrière cohort allowing a 20 years follow-up with a sufficient number of liver-related deaths. As half of the liver-related deaths were due to primary liver cancer, the second aim was to construct and validate internally two new multi-analyte tests, HR1 and HR2 (APHP-Sorbonne University Patents) for the early prediction of cancer, in patients with chronic liver diseases, without and with cirrhosis. Those tests combined apolipoprotein- A1 and haptoglobin, two "hepato-protective" proteins, with gammaglutamyl transferase, a simple marker of cytotoxicity, without specific marker of liver cancer for HR1, and with alpha-fetoprotein for HR2. Our work demonstrated that apoliporotein-A1 and haptoglobin had a prognostic value in patients without cirrhosis and drug-induced liver injury (DILI-ActiTest, APHP-Sorbonne University patent), and in patients with chronic liver diseases with and mostly without cirrhosis, permitting to identify very early the patients at high risk of cancer. These advantages of these proteins were unknown when our project started in 1997. A surveillance algorithm combining HR1 and HR2 in patients older than 50-year permitted to detect one cancer every 10 patients screened. For the third aim, the improvement of blood test for the diagnosis of steatosis and NASH, two new quantitative tests have been constructed and internally validated (APHPSorbonne University Patents), SteatoTest-2 and Nash-Test-2. To manage patients with metabolic risk, these tests have been constructed to reproduce as well as possible the pathologist report of the biopsy, that is estimating the presence and the severity of the elementary histological features: steatosis, inflammatory activity and fibrosis. For this reason a long methodological analysis has been performed to better use as reference the scoring systems now uniformized and recommended by European and American pathologists. The main limitations of our works were the absence of large external validations in patients with metabolic risk, in order to reproduce our results, especially according to a conflict of interest. For the other blood tests widely used in chronic viral hepatitis and alcoholic liver disease, as well as the first generation used in NAFLD, the independent external validations has confirmed the initial performances
Husein, Salah. "Long term mortality after lower extremity amputation in South Africa." Master's thesis, Faculty of Health Sciences, 2019. http://hdl.handle.net/11427/31531.
Повний текст джерелаKrastinova, Evguenia. "Prise en charge du VIH au stade de la primo-infection." Thesis, Paris 11, 2015. http://www.theses.fr/2015PA11T013/document.
Повний текст джерелаIn France, since 2013, HIV treatment has been recommended for all HIV-infected patients independently of their CD4 count. However, when to start anti-retroviral (ARV) treatment is still an issue. This thesis aims to explore the therapeutic management of HIV at the stage of PHI in different aspects: 1) we explored how physicians in France have applied the evolving guidelines for ART initiation since 1996 2) the impact of a transient ARV treatment at PHI on immuno-virological response during 2nd treatment and 3) identification of new biomarkers prognostic of HIV progression.Most of the work presented in this thesis is based on data from the ongoing ANRS PRIMO cohort that enrolled more than 1 500 HIV infected patients enrolled at PHI since June 1996 in 94 French hospitals. All patients were antiretroviral therapy naive at baseline.The first part of the thesis analyzes the implementation of the recommendations of ARV treatment initiation between 1996 and 2010 by physicians in France, in two distinct situations: in the chronic HIV-1 infection and during primary HIV-1 infection. We have shown that the recommendations of ARV treatment initiation were widely followed. Nevertheless, there was inertia in guidelines application when changes in the recommendations took place. The time to treatment when CD4 cell counts reach the threshold to treat can be improved. 96% of the patients initiated ART when they had a CD4 cell count below the threshold to treat at entry, while treatment was less timely initiated when the CD4 threshold was reached during active follow-up (78%, p <0.001).We identified as risk factors for not being timely treated in chronic phase despite an indication for treatment: a viral load <5log (versus> 5), a lower education level and poor living conditions.The impact of ARV interruption after a first treatment initiated at PHI on the CD4 count restoration after resumption was explored by modeling the evolution of CD4 cells with linear mixed effects models with random intercept and slope. Patients who initiated ARV treatment during the chronic phase had a better immune response than patients who initiated a second course treatment after a transient ART at PHI: at 36 months, the gains in √CD4 cells / mm3 and CD4 percentage were significantly higher. However, this difference was clinically modest and further research on treatment interruptions seeking to induce post-treatment controllers is still an issue but only in research settings and under close medical surveillance. After an overview of the complex mechanisms of activation / inflammation of the immune system during primary infection we sought to identify new predictive biomarkers of disease progression. The level of sCD14 (marker of monocyte/macrophage activation and an indirect marker of microbial translocation) at the time of PHI was identified as predictive marker of CD4 decline and of risk of cardio-vascular mortality. In conclusion, although considerable progress has been made in the management of HIV, further studies are needed to optimize and adapt the treatment to the patient profile in the early stages of HIV infection
Bolinder, Gunilla. "Long-term use of smokeless tobacco : cardiovascular mortality and risk factors /." Stockholm, 1997. http://www.kibic.ki.se/ki/diss/971024boli.html.
Повний текст джерелаКниги з теми "Mortalité à long terme"
Canada, Atomic Energy of. Mortality Among Long-Term Chalk River Employees. S.l: s.n, 1986.
Знайти повний текст джерелаFarissi, Inass El. Décisions financières de long terme. Paris: Economica, 2011.
Знайти повний текст джерелаKatus, Kalev. Long-term mortality trend in the Baltic countries. Tallinn: Estonian Interuniversity Population Research Centre, 2000.
Знайти повний текст джерелаGlachant, Jérôme. Investissements et investisseurs de long terme: Rapport. Paris: Documentation Française, 2010.
Знайти повний текст джерелаAlmond, Douglas. How did schooling laws improve long-term health and lower mortality? Chicago, Ill.]: Federal Reserve Bank of Chicago, 2006.
Знайти повний текст джерелаGestion financière à long terme: Investissements et financement. Québec: Presses de l'Université du Québec, 2007.
Знайти повний текст джерелаWalque, Damien de. The long-term legacy of the Khmer Rouge period in Cambodia. [Washington, D.C: World Bank, 2004.
Знайти повний текст джерелаCosta, Dora L. Scarring and mortality selection among Civil War POWS: A long-term mortality, morbidity and socioeconomic follow-up. Cambridge, MA: National Bureau of Economic Research, 2010.
Знайти повний текст джерелаBootsma, A. Tendances climatiques à long terme pour l'agriculture à Ottawa (Ontario). Ottawa: Centre de recherches sur les terres et les ressources biologiques, 1995.
Знайти повний текст джерелаPaniccià, Renato. Short- and long-term determinants of cardiovascular mortality: An econometric assessment of the working age population in Russia, 1965-95. Helsinki: World Institute for Development Economics Research, 1997.
Знайти повний текст джерелаЧастини книг з теми "Mortalité à long terme"
Tomson, Torbjörn. "Mortality After Epilepsy Surgery." In Long-Term Outcomes of Epilepsy Surgery in Adults and Children, 125–33. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17783-0_9.
Повний текст джерелаCarr, Aaron D., and Mohamed R. Ali. "45 Long-Term Mortality After Bariatric Surgery." In Minimally Invasive Bariatric Surgery, 423–31. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1637-5_45.
Повний текст джерелаChao, C., and S. Christin-Maitre. "Devenir à moyen terme et à long terme des pubertés précoces centrales." In Puberté précoce, 93–104. Paris: Springer Paris, 2014. http://dx.doi.org/10.1007/978-2-8178-0521-4_10.
Повний текст джерелаFernández-Ramos, María Cristina, Joseba Iñaki De La Peña, Ana Teresa Herrera, Iván Iturricastillo, and Noemí Peña-Miguel. "Helping Long Term Care Coverage via Differential on Mortality?" In Mathematical and Statistical Methods for Actuarial Sciences and Finance, 345–49. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89824-7_62.
Повний текст джерелаSamsioe, Göran. "Cardiovascular Disease: Reduced Mortality with Long-Term HRT Treatment." In Medical Science Symposia Series, 119–24. Dordrecht: Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5560-1_18.
Повний текст джерелаMili, Manel, Asma Kerkeni, Asma Ben Abdallah, and Mohamed Hedi Bedoui. "ICU Mortality Prediction Using Long Short-Term Memory Networks." In Intelligent Data Engineering and Automated Learning – IDEAL 2022, 242–51. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-21753-1_24.
Повний текст джерелаArgenson, J. N., and J. M. Aubaniac. "L’arthroplastie unicompartimentale du genou analyse a long terme." In Arthrosemanagement Knie, 55–57. Heidelberg: Steinkopff, 2000. http://dx.doi.org/10.1007/978-3-642-57719-2_7.
Повний текст джерелаGallagher, I. M., A. Clow, and V. Glover. "Long term administration of (—)-deprenyl increases mortality in male Wistar rats." In MAO — The Mother of all Amine Oxidases, 315–20. Vienna: Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-6499-0_32.
Повний текст джерелаKnudsen, Rune, Per-Arne Amundsen, and Anders Klemetsen. "Parasite-induced host mortality: indirect evidence from a long-term study." In Ecology, behaviour and conservation of the charrs, genus Salvelinus, 257–65. Dordrecht: Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-017-1352-8_23.
Повний текст джерелаGracon, Stephen, Fraser Smith, Toni Hoover, David Knopman, Lon Schneider, Kenneth Davis, and Sheela Talwalker. "Long-Term Tacrine Treatment: Effect on Nursing Home Placement and Mortality." In Alzheimer Disease, 205–9. Boston, MA: Birkhäuser Boston, 1997. http://dx.doi.org/10.1007/978-1-4612-4116-4_30.
Повний текст джерелаТези доповідей конференцій з теми "Mortalité à long terme"
Ebert, Philippe. "Archivage long terme du Falcon 7X." In Le nucléaire accélère sa transformation numérique. Les Ulis, France: EDP Sciences, 2017. http://dx.doi.org/10.1051/jtsfen/2017len2.3.
Повний текст джерелаRinaldo, L., A. Bhargav, C. Arnold Fiebelkorn, and G. Lanzino. "E-116 Long-term mortality after carotid stenting." In SNIS 17TH ANNUAL MEETING. BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd., 2020. http://dx.doi.org/10.1136/neurintsurg-2020-snis.148.
Повний текст джерелаBerthot, Alexis, Vincent Rey, and Philippe Fraunie. "Modélisation de l'évolution à long-terme du trait de côte." In Journées Nationales Génie Côtier - Génie Civil. Editions Paralia, 2000. http://dx.doi.org/10.5150/jngcgc.2000.015-b.
Повний текст джерелаRibet, I., C. Martin, and A. Rodrigues. "Le comportement à long terme des colis de déchets vitrifiés." In Les matériaux pour le stockage géologique des déchets. Les Ulis, France: EDP Sciences, 2016. http://dx.doi.org/10.1051/jtsfen/2016les02.
Повний текст джерелаKnappe-Drzikova, B., S. Maasberg, A. Sturm, B. Wiedenmann, A. Pascher, and UF Pape. "MALNUTRITION PREDICTS LONG-TERM MORTALITY IN HOSPITALIZED GASTROENTEROLOGICAL PATIENTS." In Nutrition 2017 – Ernährung: eine multiprofessionelle Herausforderung. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1603241.
Повний текст джерелаKeppler, Jan-Horst. "Coûts de système dans le court et dans le long terme." In Nucléaire et EnR : des technologies complémentaires pour la transition énergétique. Les Ulis, France: EDP Sciences, 2017. http://dx.doi.org/10.1051/jtsfen/2017nuc08.
Повний текст джерелаWang, Chen Yu, Kirsten Kangelaris, David R. Janz, Addison K. May, Gordon R. Bernard, Michael A. Matthay, Carolyn S. Calfee, and Lorraine B. Ware. "Long Term Mortality In Clinical Acute Lung Injury Is Dramatically Higher Than Hospital Mortality." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2297.
Повний текст джерелаChasco Eguilaz, Leyre, Amaia Aramburu Ojembarrena, Ane Antón Ladislao, Francisco Javier Moraza Cortés, Susana Aizpiri Rivero, María Gorordo Unzueta, and Cristóbal Esteban González. "Influence of muscle strength on long-term mortality in COPD." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2592.
Повний текст джерелаRuiz Iturriaga, Luis Alberto, Leyre Serrano Fernandez, Lorea Martinez-Indart, Ainhoa Gomez Bonilla, Beatriz Gonzalez Quero, Amaia Artaraz Ereño, Borja Ortiz De Urbina Antia, Pedro Pablo España Yandiola, and Rafael Zalacain Jorge. "Long – term mortality in patients with pneumococcal and legionella pneumonia." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4542.
Повний текст джерелаGiles, Rachel. "Long-term therapy with evolocumab associated with lower CV mortality." In ESC Congress 2022, edited by Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/07bc281c.
Повний текст джерелаЗвіти організацій з теми "Mortalité à long terme"
Johansson, Åsa, Yvan Guillemette, Fabrice Murtin, David Turner, Giuseppe Nicoletti, Christine de la Maisonneuve, Guillaume Bousquet, and Francesca Spinelli. Horizon 2060 : Perspectives de croissance économique globale à long terme. Organisation for Economic Co-Operation and Development (OECD), November 2012. http://dx.doi.org/10.1787/5k8zngscq3kf-fr.
Повний текст джерелаKibele, Eva U. B., Sebastian Klüsener, and Rembrandt D. Scholz. Regional mortality disparities in Germany: long-term dynamics and possible determinants. Rostock: Max Planck Institute for Demographic Research, October 2014. http://dx.doi.org/10.4054/mpidr-wp-2014-009.
Повний текст джерелаCosta, Dora. Scarring and Mortality Selection Among Civil War POWs: A Long-Term Mortality, Morbidity and Socioeconomic Follow-Up. Cambridge, MA: National Bureau of Economic Research, December 2010. http://dx.doi.org/10.3386/w16584.
Повний текст джерелаStall, Nathan M., Kevin A. Brown, Aaron Jones, Andrew P. Costa, Vanessa Allen, Adalsteinn D. Brown, Gerald A. Evans, et al. COVID-19 and Ontario’s Long-Term Care Homes. Ontario COVID-19 Science Advisory Table, December 2020. http://dx.doi.org/10.47326/ocsat.2020.01.05.1.0.
Повний текст джерелаAnderson, Michael. As the Wind Blows: The Effects of Long-Term Exposure to Air Pollution on Mortality. Cambridge, MA: National Bureau of Economic Research, September 2015. http://dx.doi.org/10.3386/w21578.
Повний текст джерелаCook, Philip, Jan Ostermann, and Frank Sloan. Are Alcohol Excise Taxes Good For Us? Short and Long-Term Effects on Mortality Rates. Cambridge, MA: National Bureau of Economic Research, February 2005. http://dx.doi.org/10.3386/w11138.
Повний текст джерелаConley, Dalton, and Jennifer Heerwig. The Long-Term Effects of Military Conscription on Mortality: Estimates from the Vietnam-era Draft Lottery. Cambridge, MA: National Bureau of Economic Research, June 2009. http://dx.doi.org/10.3386/w15105.
Повний текст джерелаBianchi, Francesco, Giada Bianchi, and Dongho Song. The Long-Term Impact of the COVID-19 Unemployment Shock on Life Expectancy and Mortality Rates. Cambridge, MA: National Bureau of Economic Research, December 2020. http://dx.doi.org/10.3386/w28304.
Повний текст джерелаKerfoot, H. Une perspective à long terme et un plan de développement pour un service canadien de données toponymiques numériques. Natural Resources Canada/ESS/Scientific and Technical Publishing Services, 1991. http://dx.doi.org/10.4095/298397.
Повний текст джерелаDai, Xiao-Ce, Lan Ma, Yun-Tao Zhao, Wan-Jie Gu, and Ying Dai. Association between off-hours admission and short-term and long-term mortality in acute myocardial infarction: a meta-analysis and meta-regression. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0041.
Повний текст джерела